Copyright Reports & Markets. All rights reserved.

Global Antibiotics Active Pharmaceutical Ingredient Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Penicillin Antibiotics
    • 1.2.3 Cephalosporins
    • 1.2.4 Carbapenem Antibiotics
  • 1.3 Market by Application
    • 1.3.1 Global Antibiotics Active Pharmaceutical Ingredient Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Pharmaceutical Companies
    • 1.3.3 Contract Manufacturing Organizations (CMOs)
    • 1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Perspective (2016-2027)
  • 2.2 Antibiotics Active Pharmaceutical Ingredient Growth Trends by Regions
    • 2.2.1 Antibiotics Active Pharmaceutical Ingredient Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Antibiotics Active Pharmaceutical Ingredient Historic Market Share by Regions (2016-2021)
    • 2.2.3 Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Regions (2022-2027)
  • 2.3 Antibiotics Active Pharmaceutical Ingredient Industry Dynamic
    • 2.3.1 Antibiotics Active Pharmaceutical Ingredient Market Trends
    • 2.3.2 Antibiotics Active Pharmaceutical Ingredient Market Drivers
    • 2.3.3 Antibiotics Active Pharmaceutical Ingredient Market Challenges
    • 2.3.4 Antibiotics Active Pharmaceutical Ingredient Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Antibiotics Active Pharmaceutical Ingredient Players by Revenue
    • 3.1.1 Global Top Antibiotics Active Pharmaceutical Ingredient Players by Revenue (2016-2021)
    • 3.1.2 Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Players (2016-2021)
  • 3.2 Global Antibiotics Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Antibiotics Active Pharmaceutical Ingredient Revenue
  • 3.4 Global Antibiotics Active Pharmaceutical Ingredient Market Concentration Ratio
    • 3.4.1 Global Antibiotics Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Antibiotics Active Pharmaceutical Ingredient Revenue in 2020
  • 3.5 Antibiotics Active Pharmaceutical Ingredient Key Players Head office and Area Served
  • 3.6 Key Players Antibiotics Active Pharmaceutical Ingredient Product Solution and Service
  • 3.7 Date of Enter into Antibiotics Active Pharmaceutical Ingredient Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Antibiotics Active Pharmaceutical Ingredient Breakdown Data by Type

  • 4.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Type (2016-2021)
  • 4.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Type (2022-2027)

5 Antibiotics Active Pharmaceutical Ingredient Breakdown Data by Application

  • 5.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Application (2016-2021)
  • 5.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
  • 6.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type
    • 6.2.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
    • 6.2.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
    • 6.2.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
  • 6.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application
    • 6.3.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
    • 6.3.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
    • 6.3.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
  • 6.4 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country
    • 6.4.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
    • 6.4.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
  • 7.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type
    • 7.2.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
    • 7.2.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
    • 7.2.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
  • 7.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application
    • 7.3.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
    • 7.3.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
    • 7.3.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
  • 7.4 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country
    • 7.4.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
    • 7.4.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
  • 8.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type
    • 8.2.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application
    • 8.3.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region
    • 8.4.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
  • 9.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type
    • 9.2.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
    • 9.2.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
    • 9.2.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
  • 9.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application
    • 9.3.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
    • 9.3.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
    • 9.3.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
  • 9.4 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country
    • 9.4.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
    • 9.4.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
  • 10.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type
    • 10.2.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application
    • 10.3.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country
    • 10.4.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sandoz International
    • 11.1.1 Sandoz International Company Details
    • 11.1.2 Sandoz International Business Overview
    • 11.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.1.4 Sandoz International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.1.5 Sandoz International Recent Development
  • 11.2 Centrient Pharmaceuticals
    • 11.2.1 Centrient Pharmaceuticals Company Details
    • 11.2.2 Centrient Pharmaceuticals Business Overview
    • 11.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.2.4 Centrient Pharmaceuticals Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.2.5 Centrient Pharmaceuticals Recent Development
  • 11.3 CordenPharma International
    • 11.3.1 CordenPharma International Company Details
    • 11.3.2 CordenPharma International Business Overview
    • 11.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.3.4 CordenPharma International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.3.5 CordenPharma International Recent Development
  • 11.4 ACS DOBFAR
    • 11.4.1 ACS DOBFAR Company Details
    • 11.4.2 ACS DOBFAR Business Overview
    • 11.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.4.4 ACS DOBFAR Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.4.5 ACS DOBFAR Recent Development
  • 11.5 Nanjing Dorra Pharmaceutical Technology
    • 11.5.1 Nanjing Dorra Pharmaceutical Technology Company Details
    • 11.5.2 Nanjing Dorra Pharmaceutical Technology Business Overview
    • 11.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.5.4 Nanjing Dorra Pharmaceutical Technology Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.5.5 Nanjing Dorra Pharmaceutical Technology Recent Development
  • 11.6 DAEWOONG PHARMACEUTICAL
    • 11.6.1 DAEWOONG PHARMACEUTICAL Company Details
    • 11.6.2 DAEWOONG PHARMACEUTICAL Business Overview
    • 11.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.6.4 DAEWOONG PHARMACEUTICAL Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.6.5 DAEWOONG PHARMACEUTICAL Recent Development
  • 11.7 Parabolic Drugs
    • 11.7.1 Parabolic Drugs Company Details
    • 11.7.2 Parabolic Drugs Business Overview
    • 11.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.7.4 Parabolic Drugs Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.7.5 Parabolic Drugs Recent Development
  • 11.8 Penam Laboratories
    • 11.8.1 Penam Laboratories Company Details
    • 11.8.2 Penam Laboratories Business Overview
    • 11.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.8.4 Penam Laboratories Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.8.5 Penam Laboratories Recent Development
  • 11.9 ASIATIC DRUGS & PHARMACEUTICALS
    • 11.9.1 ASIATIC DRUGS & PHARMACEUTICALS Company Details
    • 11.9.2 ASIATIC DRUGS & PHARMACEUTICALS Business Overview
    • 11.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.9.4 ASIATIC DRUGS & PHARMACEUTICALS Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Development
  • 11.10 Fresenius Kabi
    • 11.10.1 Fresenius Kabi Company Details
    • 11.10.2 Fresenius Kabi Business Overview
    • 11.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.10.4 Fresenius Kabi Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.10.5 Fresenius Kabi Recent Development
  • 11.11 The United Laboratories International Holdings
    • 11.11.1 The United Laboratories International Holdings Company Details
    • 11.11.2 The United Laboratories International Holdings Business Overview
    • 11.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.11.4 The United Laboratories International Holdings Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.11.5 The United Laboratories International Holdings Recent Development
  • 11.12 Aurobindo Pharma Limited
    • 11.12.1 Aurobindo Pharma Limited Company Details
    • 11.12.2 Aurobindo Pharma Limited Business Overview
    • 11.12.3 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.12.4 Aurobindo Pharma Limited Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.12.5 Aurobindo Pharma Limited Recent Development
  • 11.13 Unimark Remedies
    • 11.13.1 Unimark Remedies Company Details
    • 11.13.2 Unimark Remedies Business Overview
    • 11.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.13.4 Unimark Remedies Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.13.5 Unimark Remedies Recent Development
  • 11.14 Savior Lifetec
    • 11.14.1 Savior Lifetec Company Details
    • 11.14.2 Savior Lifetec Business Overview
    • 11.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Introduction
    • 11.14.4 Savior Lifetec Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
    • 11.14.5 Savior Lifetec Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Antibiotics Active Pharmaceutical Ingredient Scope and Market Size
    Antibiotics Active Pharmaceutical Ingredient market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibiotics Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Penicillin Antibiotics
    Cephalosporins
    Carbapenem Antibiotics

    Segment by Application
    Pharmaceutical Companies
    Contract Manufacturing Organizations (CMOs)
    Contract Development & Manufacturing Organizations (CDMOs)

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Sandoz International
    Centrient Pharmaceuticals
    CordenPharma International
    ACS DOBFAR
    Nanjing Dorra Pharmaceutical Technology
    DAEWOONG PHARMACEUTICAL
    Parabolic Drugs
    Penam Laboratories
    ASIATIC DRUGS & PHARMACEUTICALS
    Fresenius Kabi
    The United Laboratories International Holdings
    Aurobindo Pharma Limited
    Unimark Remedies
    Savior Lifetec

    Buy now